Telo Genomics Appoints Gregg Mayer to Lead the Development of the Company’s Industry Partnership Strategy
February 03, 2021 at 07:25 pm IST
Telo Genomics Corp. announced that the Company has entered into a consulting agreement with the biomedical industry veteran Gregg Mayer, Founder & Principal of BioCore Strategies, LLC, Boston, Massachusetts, USA, and former executive of Abbott Diagnostics, Siemens and a number of early-stage biopharma and medical device companies, both public and privately held. Mr. Mayer will lead TELO’s efforts to develop and execute the Company’s industry partnership strategy with Biopharma and Diagnostics industries.